394
Participants
Start Date
August 15, 2022
Primary Completion Date
October 7, 2022
Study Completion Date
October 7, 2022
Candidate-1
Biological
Candidate-2
Biological
Candidate-3
Biological
Candidate-4
Biological
Candidate-5
Biological
Candidate-6
Biological
Candidate Control
Biological
13vPnC
13-valent pneumococcal conjugate vaccine
PCV15
15-valent pneumococcal conjugate vaccine
Centennial Medical Group, Elkridge
Alliance for Multispecialty Research, LLC, Norfolk
Accellacare - Wilmington, Wilmington
Indago Research & Health Center, Inc, Hialeah
Qps-Mra, Llc, South Miami
Proactive Clinical Research,LLC, Fort Lauderdale
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy
Prism Research LLC dba Nucleus Network, Saint Paul
DM Clinical Research, Tomball
Clinical Trials of Texas, LLC, San Antonio
Diagnostics Research Group, San Antonio
IMA Clinical Research San Antonio, San Antonio
J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City
J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City
Orange County Research Center, Tustin
Diablo Clinical Research, Inc., Walnut Creek
Clinical Research Consulting, Milford
South Jersey Infectious Disease, Somers Point
Lead Sponsor
Pfizer
INDUSTRY